Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
TAMSULOSIN HYDROCHLORIDE
Primecrown 2010 Ltd
G04CA02
TAMSULOSIN HYDROCHLORIDE
400 Microgram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
tamsulosin
Authorised
2012-10-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Omnexel 400 micrograms, prolonged release tablets, film-coated 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged release film-coated tablet contains 0.4 mg tamsulosin hydrochloride. Excipients: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated, prolonged release tablet. _Product imported from the UK:_ Approximately 9 mm in diameter, round, bi-convex, yellow, film-coated and debossed with the code '04' 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral use. One tablet daily. Omnexel can be taken independently of food. The tablet must be swallowed whole and not be crunched or chewed as this interferes with the prolonged release of the active substance. No dose adjustment is warranted in renal impairment. No dose adjustment is warranted in patients with mild to moderate hepatic insufficiency (see also 4.3, Contraindications). Paediatric population There is no relevant indication for use of Omnexel in children. The safety and efficacy of tamsulosin in children <18 years have not been established. Currently available data are described in section 5.1 4.3 CONTRAINDICATIONS Hypersensitivity to tamsulosin hydrochloride, including drug-induced angioedema or to any of the excipients. A history of orthostatic hypotension. Severe hepatic insufficiency. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 17/10/2012_ _CRN 2117326_ _page number: 1_ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with other 1 -adrenoceptor antagonists, a reduction in blood pressure can occur in individual cases Прочитајте комплетан документ